NLNK - NewLink +16% on NLG207 license agreement
- NewLink Genetics (NASDAQ:NLNK) enters into a license agreement with Ellipses Pharma.
- More news on: NewLink Genetics Corporation, Healthcare stocks news, Stocks on the move, Read more ...
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get NLNK Alerts
News, Short Squeeze, Breakout and More Instantly...